Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Centuri Holdings | CTRI | Sep 24, 2024 | 15.95 | -3.51 |
Centurion Acquisition | ALFUU | Sep 24, 2024 | 10.04 | +0.30 |
Century Aluminium | CENX | Sep 24, 2024 | 15.38 | +4.98 |
Century Casinos | CNTY | Sep 24, 2024 | 2.31 | -3.75 |
Century Communities | CCS | Sep 24, 2024 | 101.92 | -1.02 |
Century Therapeutics | IPSC | Sep 24, 2024 | 1.50 | -3.55 |
Cepton | CPTN | Sep 24, 2024 | 3.05 | 0.00 |
Ceragon Networks | CRNT | Sep 24, 2024 | 2.66 | +1.92 |
Cerence | CRNC | Sep 24, 2024 | 2.62 | +4.38 |
CERo Therapeutics | CERO | Sep 24, 2024 | 0.09 | -14.35 |
Certara | CERT | Sep 24, 2024 | 10.70 | -1.47 |
Cerus | CERS | Sep 24, 2024 | 1.80 | +1.12 |
CervoMed | CRVO | Sep 24, 2024 | 15.20 | -2.56 |
CEVA | CEVA | Sep 24, 2024 | 23.99 | +2.70 |
CF Acquisition VII A | CFFS | Sep 24, 2024 | 11.08 | 0.00 |
CF Bankshares | CFBK | Sep 24, 2024 | 20.88 | -2.16 |
CF Industries | CF | Sep 24, 2024 | 84.89 | +1.95 |
CFSB Bancorp | CFSB | Sep 24, 2024 | 6.67 | +0.30 |
CG Oncology | CGON | Sep 24, 2024 | 36.52 | -4.75 |
CGI | GIB | Sep 24, 2024 | 114.53 | +0.90 |
Chain Bridge I SPAC A | CBRG | Sep 24, 2024 | 11.26 | 0.00 |
Chain Bridge I Units | CBRGU | Sep 24, 2024 | 11.11 | 0.00 |
Champion Homes | SKY | Sep 24, 2024 | 92.68 | +0.14 |
Champions Oncology | CSBR | Sep 24, 2024 | 4.71 | +2.84 |
ChampionX | CHX | Sep 24, 2024 | 31.00 | +0.06 |
Chanson International | CHSN | Sep 24, 2024 | 2.86 | +13.94 |
ChargePoint | CHPT | Sep 24, 2024 | 1.42 | +5.19 |
Charles & Colvard | CTHR | Sep 24, 2024 | 1.72 | +2.69 |
Charles River Laboratories International | CRL | Sep 24, 2024 | 200.62 | -1.55 |
Charles Schwab | SCHW | Sep 24, 2024 | 64.58 | -0.54 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.